Hayashi S, Sugiyama T, Yachi A, Yokota K, Hirai Y, Oguma K, Fujii N
Department of Microbiology, School of Medicine, Sapporo Medical University, Japan.
J Gastroenterol. 1997 Oct;32(5):593-7. doi: 10.1007/BF02934107.
Helicobacter pylori is a major etiological agent in gastroduodenal disorders, with the adhesion of H. pylori to gastric epithelial cells being the initial step of H. pylori infection. Inhibition of H. pylori adhesion is thus a therapeutic target in preventing H. pylori infection. We evaluated the effect of ecabet sodium, an antiulcer agent, on H. pylori adhesion to gastric epithelial cells, using our previously established enzyme-linked immunosorbent assay. The adhesion of H. pylori was significantly inhibited by ecabet sodium in a dose-dependent manner. Our studies suggest that ecabet sodium inhibits the adhesion of H. pylori to gastric epithelial cells.
幽门螺杆菌是胃十二指肠疾病的主要病原体,幽门螺杆菌黏附于胃上皮细胞是幽门螺杆菌感染的起始步骤。因此,抑制幽门螺杆菌黏附是预防幽门螺杆菌感染的一个治疗靶点。我们使用先前建立的酶联免疫吸附测定法,评估了抗溃疡药物依卡倍特钠对幽门螺杆菌黏附胃上皮细胞的影响。依卡倍特钠以剂量依赖的方式显著抑制了幽门螺杆菌的黏附。我们的研究表明,依卡倍特钠可抑制幽门螺杆菌黏附胃上皮细胞。